medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 2

<< Back Next >>

Med Int Mex 2022; 38 (2)

Multisystemic inflammatory syndrome of the adult post-COVID-19.

Herrera-García JC, Arellano-Montellano EI, Nuche-Salazar NP, Acosta-Sánchez H, Téllez-Bautista M, Enciso-Figueroa G, Balandrano-TrujilloTJ, Delabra-Navarro F

Language: Spanish
References: 17
Page: 471-475
PDF size: 448.07 Kb.


ABSTRACT

Background: Multisystemic inflammatory syndrome of the adult, a new condition associated with an irregular immune response similar to that of children, is characterized by shock, heart failure or persistent hypotension, dyspnea on exertion, mild-moderate hypoxemia, gastric symptoms and elevated markers of systemic inflammation after severe COVID-19 pneumonia.
Clinical case: A 56-year-old patient, uncontrolled diabetic, who presented symptoms associated with dyspnea, desaturation, chest pain and persistent fever, previously with severe pneumonia after one month of treatment. He was treated with oxygen, steroids and antibiotics for 3 weeks, but his symptoms worsened and he developed severe orthopnea, hypotension, chest pain, dyspnea at rest and severe desaturation, as well as elevation of inflammation markers (C-reactive protein, ESR, D-dimer, ferritin). Tomography of the chest showed residual pneumonia based on consolidation and ground glass. Echocardiogram evidenced diastolic dysfunction, myopericarditis and secondary endocarditis. Multisystemic inflammatory syndrome of the adult was diagnosed and patient was treated with IV immunoglobulin and steroid with a favorable response to treatment.
Conclusions: This case shows that the adult systemic inflammatory syndrome is a differential diagnosis in a patient with shock of unknown etiology, heart failure and severe dyspnea previously infected by SARS-CoV-2. Immunoglobulin and steroid are the effective first-line treatment with excellent clinical response.


REFERENCES

  1. Manabe T, Akatsu H, Kotani K, Kudo K. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020. Respir Investig 2020; 58 (5): 409-18. doi: 10.1016/j.resinv.2020.05.005.

  2. Patel P, DeCuir J, Abrams J, Campbell A, Godfred-Cato S, Belay E, et al. Clinical characteristics of multisystem inflammatory syndrome in adults: a systematic review. JAMA Network Open 2021; 4 (9): e2126456. doi: 10.1001/ jamanetworkopen.2021.26456.

  3. Godfred-Cato S, Bryant B, Leung J, Oster ME, et al. COVID- 19-associated multisystem inflammatory syndrome in children. United States, March-July 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (32): 1074-80. doi: 10.15585/ mmwr.mm6932e2.

  4. Gruber CN, Patel RS, Trachtman R, Lepow L, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 2020; 183 (4): 982-995.e14. doi: 10.1016/j.cell.2020.09.034.

  5. Hékimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, et al. COVID-19 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. Chest 2021; 159 (2): 657-662. doi: 10.1016/j.chest.2020.08.2099.

  6. Morris SB, Schwartz NG, Patel P, Abbo L, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection. United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (40): 1450-6. http://dx.doi.org/10.15585/ mmwr.mm6940e1.

  7. Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, Gupta A. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev 2021; 38: 51-57. doi: 10.1016/j.prrv.2020.08.001.

  8. Chowdhary A, Joy E, Plein S, Abdel-Rahman SE. Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection. Eur Heart J Cardiovasc Imaging 2021; 22 (5): e17. https://doi.org/10.1093/ehjci/jeaa232.

  9. Shaigany S, Gnirke M, Guttmann A, Chong H, Meehan S, Raabe V, Louie E, Solitar B, Femia A. An adult with Kawasakilike multisystem inflammatory syndrome associated with COVID-19. Lancet 2020; 396 (10246): e8-10. doi: 10.1016/ S0140-6736(20)31526-9.

  10. Fox SE, Lameira FS, Rinker EB, Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19. Ann Intern Med 2020; 173 (12): 1025-7. DOI: 10.7326/L20-0882.

  11. Tenforde MW, Morris SB. Multisystem inflammatory syndrome in adults: coming into focus. Chest 2021; 159 (2): 471-2. doi: 10.1016/j.chest.2020.09.097.

  12. Parker A, Louw EH, Lalla U, Koegelenberg CFN, et al. Multisystem inflammatory syndrome in adult COVID-19 patients. S Afr Med J 2020; 110 (10): 957-958. doi:10.7196/ SAMJ.2020.v110i10.15244.

  13. Ahsan T, Rani B. A case of multisystem inflammatory syndrome post-COVID-19 infection in an adult. Cureus 2020; 12 (12): e11961. doi:10.7759/cureus.11961.

  14. Chug L, Cabrera NM, Mathew J, Lock J, Burke L, Sendon C. Multisystem inflammatory syndrome in an adult associated with COVID-19. Crit Care Med 2020; 49 (1): 92. doi:10.1097/01.ccm.0000726740.59021.c1.

  15. Balan S, Beauchamps L, Gonzales-Zamora JA, Vu C, et al. Recovery does not always signal the end of the battle: a case of post SARS-CoV-2 multisystem inflammatory syndrome in an adult. IDCases 2021; 24: e01067. doi:10.1016/j. idcr.2021.e01067.

  16. Amato MK, Hennessy C, Shah K, Mayer J. Multisystem inflammatory syndrome in an adult. J Emerg Med 2021; 61 (1): e1-e3. doi:10.1016/j.jemermed.2021.02.007.

  17. Yamada Y, Fujinami K, Eguchi T, Takefuji H, Mori N. Multisystem inflammatory syndrome in adults after mild SARS-CoV-2 infection, Japan. Emerg Infect Dis 2021; 27 (6): 1740-1742. doi:10.3201/eid2706.210728.




2020     |     www.medigraphic.com